Impaired biological activity of erythropoietin by cyanate carbamylation

Blood Purification

Volumn 18, Issue 1, 2000, Pages 13-17

  Mun, Kyo Cheol ^a   Golper, Thomas A ^b  

^a Keimyung University School of Medicine   (South Korea)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Carbamylation; Cyanate; Dialysis; Erythropoietin; Urea

Indexed keywords

CYANIC ACID; ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; TRINITROBENZENESULFONIC ACID; UREA;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIALYSIS; ERYTHROCYTE COUNT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; KIDNEY FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033982372     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014403     Document Type: Article

References (17)

1. Remuzzi G, Rossi EC: Hematologic consequence of renal failure: in Brenner BM (ed): Brenner and Rector's the kidney, cd 5. Philadelphia, Saunders, 1996, vol 2, pp 2170-2186.
2. Morris K, Coulthard M: End-stage kidneys are capable of increased erythropoiet n production. Pediatr Nephrol 1993;7:273-275.
3. Wallner SF, Vautrin RM: Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med 1981;97:170-178.
4. Ifudu O, Feldman J, Friedman BA: The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996;334:420-425.
5. Opatrna S, Opatrny K Jr, Cejkova P, Sefrna F, Hostasova A, Opatrny K: Relationship between anemia and adequacy of continuous ambulatory peritoneal dialysis. Nephron 1997;77: 359-360.
6. Stojimirovic B, Grujic AG: The effect of hemodialysis and continuous peritoneal dialysis on renal anemia. Srp Arh Celok Lek 1997;125: 163-167.
7. Marier JR, Rose D: Determination of cyanate, a study of its accumulation in aqueous solutions of urea. Anal Biochem 1964;7:304-314.
8. Knochel JP, Seldin DW: The pathophysiology of uremia; in Brenner BM, Rector FC (eds): The Kidney. Philadelphia, Saunders, 1976, pp 1448-1485.
9. Fluckiger R, Harmon W, Meier W, Gabbay KH: Hemoglobin carbamylation in uremia. N Engl J Med 1981;304:823-827.
10. Kraus LM, Jones MR, Kraus AP Jr: Essential carbamoyl-amino acids formed in vivo in patients with end-stage renal disease managed by continuous ambulatory peritoneal dialysis: Isolation, identification, and quantitation. J Lab Clin Med 1998;131:425-431.
11. Roxborough HE, Millar CA, McEneny J, Young IS: Carbamylation inhibits the ferroxidase activity of caeruloplasmin. Biochem Biophys Res Commun 1995;214:1073-1078.
12. Stim J, Shaykh M, Anwar F, Ansari A, Arruda JAL, Dunca G: Factors determining hemoglobin carbamylation in renal failure. Kidney Int 1995;48:1605-1610.
13. Balion CM, Draisey TF, Thibert RJ: Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int 1998;53:488-495.
14. Nilsson L, Lundquist P, Kagedal B, Larsson R: Plasma cyanate concentrations in chronic renal failure. Clin Chem 1996;42:482-483.
15. Horkko S, Savolaincn MJ, Kervinen K, Kesanicmi YA: Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int 1992;41:1175-1181.
16. Allebban Z, Gibson LA, Lange RD, Jago TL, Strickland KM, Johnson DL, Ichiki AT: Effect of spaceflight on rat erythroid parameters. J Appl Physiol 1996;81:117-122.
17. Satake R, Kozutsumi H, Takeuchi M, Asano K: Chemical modification of erythropoietin: An increase in vitro activity by guanidination. Biochim Biophys Acta 1990;1038:125-129.